Skip to main content
Cerebral and Tissue Oximetry Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, France, Japan - Size and Forecast 2024-2028

Cerebral and Tissue Oximetry Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, France, Japan - Size and Forecast 2024-2028

Published: Jun 2024 168 Pages SKU: IRTNTR41566

Market Overview at a Glance

$96.3 Mn
Market Opportunity
8.08%
CAGR
7.3
YoY growth 2023-2024(%)

Cerebral And Tissue Oximetry Devices Market Size 2024-2028 

The cerebral and tissue oximetry devices market size is forecast to increase by USD 96.3 million at a CAGR of 8.08% between 2023 and 2028.

  • The market is witnessing significant growth due to the increasing utilization of these devices in cardiac surgical procedures. The use of these devices enables real-time monitoring of oxygen levels In the brain and tissues, ensuring optimal patient care and reducing the risk of complications. Technological advancements in cerebral and tissue oximetry devices are also driving market growth, as innovations lead to more accurate and non-invasive measurement techniques. However, the high cost of these devices remains a major challenge for market expansion, limiting their accessibility to a larger patient population. Despite this, the market is expected to continue growing, as the benefits of early detection and intervention in surgical procedures become increasingly recognized.

    • What will be the Size of the Cerebral And Tissue Oximetry Devices Market During the Forecast Period?

    Cerebral And Tissue Oximetry Devices Market Size

     Request Free Sample

  • The market encompasses technologies that measure oxygen saturation levels in cerebral tissues and muscles, extending beyond traditional pulse oximetry. These devices employ sensors, such as oximeter probes with light detectors and fiber-optic light sources, to monitor cerebral oxygenation levels in various settings, including research, neonatal care, surgical procedures, and outpatient settings. The market is driven by the increasing number of surgical procedures, particularly in operating rooms, and the growing focus on improving patient outcomes and reducing complications. High device costs and varying reimbursement policies present challenges, while advancements in AI integration and wireless connectivity enhance the market's appeal. Medical specialties, including neurology and liver transplantation, and chronic diseases, such as neurological conditions, are significant end-users.
  • Physicians rely on these devices to monitor patients with critical cerebral oxygenation needs, ensuring optimal care for premature infants, patients undergoing surgeries, and those with chronic conditions.

    • How is this Cerebral And Tissue Oximetry Devices Industry segmented and which is the largest segment?

    The cerebral and tissue oximetry devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

    • Product
      • Modular devices
      • Handheld devices
    • End-user
      • Hospitals
      • Clinics
    • Geography
      • North America
        • US
      • Europe
        • Germany
        • France
      • Asia
        • China
        • Japan
      • Rest of World (ROW)

      By Product Insights

      • The modular devices segment is estimated to witness significant growth during the forecast period.

      Handheld cerebral and tissue oximetry devices are compact, non-invasive tools used for measuring oxygen saturation levels in various tissues, including muscles, liver, and cerebral tissues. These devices offer real-time data, making them indispensable in various medical settings, such as surgeries in ICUs, research settings, neonatal care for premature infants, and home healthcare. Sensor technologies, data analytics, and wireless connectivity enhance their functionality. These devices are user-friendly, portable, and flexible, allowing for monitoring in various medical specialties, including cardiovascular disorders, neurological conditions, and chronic diseases. Despite their benefits, high device costs and reimbursement policies remain challenges. Integration of AI and machine learning offers potential solutions.

      These devices are essential for surgeons and healthcare professionals in monitoring tissue oxygen levels during surgical procedures in operating rooms, outpatient settings, and minimally invasive procedures.

      Cerebral And Tissue Oximetry Devices Market Size

      Get a glance at the  Cerebral And Tissue Oximetry Devices Industry report of share of various segments Request Free Sample

      The Modular devices segment was valued at USD 114.50 million in 2018 and showed a gradual increase during the forecast period.

      Regional Analysis

      • North America is estimated to contribute 37% to the growth of the global market during the forecast period.

      Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

      Cerebral And Tissue Oximetry Devices Market Share by Geography

      For more insights on the market share of various regions, Request Free Sample

      The market in North America is currently the largest, driven by the increasing prevalence of cardiovascular diseases (CVD), growing number of surgical procedures, and US FDA approvals. The US, as the key leading country, is home to several prominent companies, such as Nonin Medical, Edwards Lifesciences, ISS, Masimo, and HyperMed Imaging, offering advanced products. These devices provide non-invasive monitoring of cerebral and tissue oxygen levels in real-time, making them essential for various medical settings, including ICUs, surgery, outpatient clinics, and research. Sensor technologies, data analytics, and wireless connectivity are key features enhancing the functionality and user-friendliness of these devices. Neonatal care, premature infants, geriatric population, and patients with neurological conditions, cardiovascular disorders, and chronic diseases benefit significantly from these devices.

      High device costs and reimbursement policies remain challenges, while AI integration and home healthcare solutions offer growth opportunities.

      Market Dynamics

      Our  researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

      What are the key market drivers leading to the rise In the adoption of Cerebral And Tissue Oximetry Devices Industry?

      Growing use of cerebral and tissue oximetry devices in cardiac surgical procedures is the key driver of the market.

    • The market has gained significant traction due to the increasing prevalence of chronic diseases, such as cardiovascular disorders, neurological conditions, and liver diseases, which require intensive care and surgeries. In healthcare settings, including ICUs and research settings, these devices are essential for non-invasive monitoring of oxygen saturation levels in muscles, liver, and cerebral tissues. Sensor technologies, such as fiber-optic light sources and oximeter probes, are used to measure oxygen levels In the forehead area, providing real-time data for surgeons and healthcare professionals. The adoption of user-friendly design, portability, and flexibility in tabletop and handheld devices has expanded their usage beyond traditional operating rooms to outpatient settings.
    • However, high device costs and reimbursement policies remain significant challenges for end-users. Integration of AI and wireless connectivity In these devices offers data analysis capabilities, enabling early detection and intervention in various medical specialties, including cardiovascular diseases, heart disease, peripheral artery disease, and neurodegenerative diseases. The geriatric population, particularly those with cerebral oxygenation issues, also benefits from these advanced monitoring systems.

      • What are the market trends shaping the Cerebral And Tissue Oximetry Devices Industry?

      Technological advances in cerebral and tissue oximetry devices is the upcoming market trend.

    • Cerebral and tissue oximetry devices are witnessing technological advancements due to the increasing demand for accurate oxygen saturation (So2) measurements in deep tissue sites. The limitations of existing cerebral and tissue oximetry devices have led to the emergence of new technologies like diffuse correlation spectroscopy (DCS), a dynamic NIRS technology. DCS is a promising tool for sensitive and rapid blood flow measurements and cerebral metabolism ratio of oxygen in deeply located tissues. companies are also adopting continuous-wave light sources instead of pulsed laser and frequency-modulated approaches to reduce device costs. These devices are essential in various settings, including surgeries in ICUs, research settings, neonatal care for premature infants, and outpatient settings.
    • The user-friendly design, portability, flexibility, and real-time data capabilities make these devices valuable for healthcare professionals, surgeons, and physicians. However, high device costs and reimbursement policies remain challenges for end-users. Integration of AI and wireless connectivity is a trend in this market, catering to medical specialties like neurological conditions, cardiovascular disorders, and geriatric population with chronic diseases. Portable and handheld devices offer convenience for home healthcare and mobile monitoring systems for heart disease, cardiac surgeries, and peripheral artery disease. Cerebral oximeter monitors with cable and oximeter probe for the forehead area, light detector, and fiber-optic light source measure oxygen levels In the brain, providing crucial information for healthcare professionals.

      • What challenges does the Cerebral And Tissue Oximetry Devices Industry face during its growth?

      High cost of cerebral and tissue oximetry devices is a key challenge affecting the industry growth.

    • Cerebral and tissue oximetry devices are essential tools used for monitoring oxygen saturation levels in various medical settings, including ICUs, surgeries, research settings, and neonatal care. These devices use sensors to detect oxygen levels in muscles, liver, and cerebral tissues, providing real-time data for healthcare professionals. Sensor technologies, such as Near-Infrared Spectroscopy (NIRS), are used for accurate monitoring, increasing the overall cost of these systems. The cost is a significant factor for end-users when purchasing cerebral and tissue oximetry devices. The cost includes the expense of monitors and sensors, maintenance, and replacement. Monitors can range from USD12,000 to USD25,000, and specialized mounting options, such as wall mounts and roll stands, can cost up to USD1,000.
    • High device costs and reimbursement policies may impact the adoption of these devices in hospitals and outpatient settings. Advanced functionalities, such as AI integration, wireless connectivity, and data analytics, are becoming increasingly popular in cerebral and tissue oximetry devices. These features enhance the capabilities of the devices, making them more user-friendly and flexible for various medical specialties, including cardiovascular disorders, neurological conditions, and chronic diseases. Portable and handheld devices offer greater portability and flexibility, making them suitable for home healthcare and mobile monitoring systems. In conclusion, the market is driven by the need for non-invasive monitoring, real-time data, and advanced functionalities.
    • However, the high cost and reimbursement policies remain significant challenges for end-users. The market is expected to grow as the demand for accurate and reliable oxygen saturation monitoring increases in various medical settings.

      • Exclusive Customer Landscape

      The cerebral and tissue oximetry devices market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the cerebral and tissue oximetry devices market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

      Cerebral And Tissue Oximetry Devices Market Share by Geography

       Customer Landscape

      Key Companies & Market Insights

      Companies are implementing various strategies, such as strategic alliances, cerebral and tissue oximetry devices market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

      Artinis Medical Systems - Cerebral and tissue oximetry devices employ functional near-infrared spectroscopy (fNIRS) technology to non-invasively monitor changes in cerebral blood oxygenation levels. This innovative approach allows for real-time assessment of brain function and tissue oxygenation status. The device measures the concentration of oxygenated and deoxygenated hemoglobin In the brain, providing valuable insights into metabolic activity and oxygen utilization. This information can be instrumental in various clinical applications, including neurosurgery, intensive care, and research settings. The device's design prioritizes user-friendliness and accuracy, making it a valuable addition to healthcare professionals' toolkit. By offering this advanced brain imaging solution, the company is committed to advancing the field of neurodiagnostics and contributing to improved patient outcomes.

      The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

      • Artinis Medical Systems
      • Boston Scientific Corp.
      • Edwards Lifesciences Corp.
      • GE Healthcare Technologies Inc.
      • Hamamatsu Photonics KK
      • HyperMed Imaging Inc.
      • ISS Inc.
      • Masimo Corp.
      • Medtronic Plc
      • Moor Instruments Ltd.
      • Nonin Medical Inc.
      • Sotera Health Co.
      • Spectros Medical Devices Inc.
      • Terumo Corp.
      • ViOptix Inc.

      Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

      Research Analyst Overview

      Cerebral and tissue oximetry devices refer to advanced medical technologies designed to monitor oxygen saturation levels in various tissues, including cerebral tissues. These devices play a crucial role in various medical settings, from intensive care units to surgical procedures and home healthcare. Sensors are the core component of these devices, responsible for detecting oxygen levels in tissues. Muscles and the liver are common targets for oxygen saturation monitoring, as they provide valuable insights into the body's overall health. In research settings, cerebral oximetry devices are used to study the effects of various conditions on cerebral oxygenation levels. Sensor technologies have evolved significantly over the years, with data analytics capabilities becoming increasingly important.

      Handheld devices and tabletop systems offer portability and flexibility, making non-invasive monitoring a reality for a wide range of medical specialties. Real-time data is essential for surgeons and healthcare professionals to make informed decisions during surgical procedures and in intensive care settings. Traditional operating rooms and outpatient settings are not the only environments where cerebral oximetry devices are used. Minimally invasive procedures and home healthcare settings also benefit from these advanced monitoring systems. High device costs and complex reimbursement policies can pose challenges for widespread adoption, but the potential benefits far outweigh these obstacles. Artificial intelligence (AI) integration and wireless connectivity are two emerging trends in cerebral oximetry devices.

      AI can help analyze vast amounts of data to identify patterns and trends, providing valuable insights for healthcare professionals. Wireless connectivity enables remote monitoring, making it easier for patients to receive care from the comfort of their own homes. Cerebral oximetry devices are not limited to cardiovascular disorders and heart disease. Neurological conditions, such as neurodegenerative diseases and geriatric populations, also benefit from these advanced monitoring systems. The flexibility of these devices allows for monitoring in various medical settings, from operating rooms to home healthcare. The use of cerebral oximetry devices is not limited to surgeons and physicians.

      Nurses, technicians, and other healthcare professionals also play a critical role In the successful implementation and utilization of these devices. The data analysis capabilities of these devices provide valuable insights into tissue oxygen levels, helping healthcare professionals make informed decisions and improve patient outcomes. In conclusion, cerebral and tissue oximetry devices represent a significant advancement in medical technology, offering real-time monitoring of oxygen saturation levels in various tissues. These devices are essential in various medical settings, from intensive care units to surgical procedures and home healthcare. The integration of AI and wireless connectivity, along with the flexibility and portability of these devices, make them an invaluable tool for healthcare professionals in managing a wide range of medical conditions.

      Market Scope

      Report Coverage

      Details

      Page number

      168

      Base year

      2023

      Historic period

      		 2018-2022

      Forecast period

      2024-2028

      Growth momentum & CAGR

      Accelerate at a CAGR of 8.08%

      Market growth 2024-2028

      USD 96.3 million

      Market structure

      Concentrated

      YoY growth 2023-2024(%)

      7.3

      Key countries

      US, China, Germany, France, and Japan

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      What are the Key Data Covered in this Cerebral And Tissue Oximetry Devices Market Research and Growth Report?

      • CAGR of the Cerebral And Tissue Oximetry Devices industry during the forecast period
      • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
      • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
      • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
      • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
      • Thorough analysis of the market’s competitive landscape and detailed information about companies
      • Comprehensive analysis of factors that will challenge the cerebral and tissue oximetry devices market growth of industry companies

      We can help! Our analysts can customize this cerebral and tissue oximetry devices market research report to meet your requirements.

      Get in touch

       

      Table of Contents not available.

      Research Methodology

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      INFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases

      DATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts

      REPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape

      Interested in this report?

      Get your sample now to see our research methodology and insights!

      Download Now

      Frequently Asked Questions

      Cerebral And Tissue Oximetry Devices market growth will increase by $ 96.3 mn during 2024-2028.

      The Cerebral And Tissue Oximetry Devices market is expected to grow at a CAGR of 8.08% during 2024-2028.

      Cerebral And Tissue Oximetry Devices market is segmented by Product( Modular devices, Handheld devices) End-user( Hospitals, Clinics, Asia, ROW)

      Artinis Medical Systems, Boston Scientific Corp., Edwards Lifesciences Corp., GE Healthcare Technologies Inc., Hamamatsu Photonics KK, HyperMed Imaging Inc., ISS Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nonin Medical Inc., Sotera Health Co., Spectros Medical Devices Inc., Terumo Corp., ViOptix Inc. are a few of the key vendors in the Cerebral And Tissue Oximetry Devices market.

      North America will register the highest growth rate of 37% among the other regions. Therefore, the Cerebral And Tissue Oximetry Devices market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

      US, China, Germany, France, Japan

      • Growing use of cerebral and tissue oximetry devices in cardiac surgical proceduresWith the growing prevalence of CVDs is the driving factor this market.
      • such as cerebrovascular diseases is the driving factor this market.
      • cardiomyopathy is the driving factor this market.
      • and rheumatic heart diseases is the driving factor this market.
      • the demand for their efficient treatment in healthcare settings has increased. Many CVD treatments demand surgical interventions is the driving factor this market.
      • and thus is the driving factor this market.
      • the number of patients approaching healthcare settings for cardiac surgeries is increasing.Patients undergoing cardiac surgeries are exposed to the risk of adverse perioperative neurological events. Anesthesia used during cardiac surgeries can lead to oxygen deprivation/cerebral hypoxia. Thus is the driving factor this market.
      • the maintenance of adequate oxygen delivery in tissues and organs is the driving factor this market.
      • specifically in the brain is the driving factor this market.
      • is a fundamental requirement in cardiac surgical procedures. Such factors drive the adoption of advanced blood oxygenation monitoring devices such as cerebral and tissue oximetry devices.Cerebral and tissue oximetry devices are used as markers for cerebral perfusion to avoid complications related to cerebral hypoxia. These devices allow real-time monitoring of oxygen concentration during the perioperative period. These devices continuously estimate regional oxygen balance and effectively determine low regional blood flow is the driving factor this market.
      • thereby allowing timely intervention and the prevention of cerebral hypoxia during surgery. Such timely intervention capabilities enable greater confidence among surgeons while performing cardiac surgeries is the driving factor this market.
      • thereby increasing the adoption of cerebral and tissue oximetry devices in surgical wards and intensive care units across healthcare settings. Thus is the driving factor this market.
      • such factors will boost the growth of the global cerebral and tissue oximetry devices market during the forecast period. is the driving factor this market.

      The Cerebral And Tissue Oximetry Devices market vendors should focus on grabbing business opportunities from the Modular devices segment as it accounted for the largest market share in the base year.